Impact of hospital‐administered extended‐release naltrexone on readmission rates for patients with alcohol use disorder

Alcohol use disorder (AUD) is a persistent public health concern, contributing significantly to mortality and morbidity. This study aims to evaluate the impact of in-hospital extended-release naltrexone (XR-NTX) administration on alcohol-related outcomes.